Drug Approval | October 03, 2022
Lupin gets EIR from USFDA for its Ankleshwar facility
The inspection of the facility was conducted from August 16-19, 2022.
The inspection of the facility was conducted from August 16-19, 2022.
The proposed acquisition consideration represents an equity value for Myovant of $2.4 billion and an enterprise value of $2.5 billion.
The booster vaccination trial is still ongoing and further data will provide more information around safety and efficacy.
Mirabegron Extended-Release Tablets, 25 mg and 50 mg, had estimated annual sales of US $2.4 billion in US
The combination of Optym, Emmes' ophthalmology certification unit, and Clinical Edge will make the organization a leader in ophthalmic certification and training services
Sildenafil for Oral Suspension (RLD Revatio) had estimated annual sales of US $64 million in the US
Dr. Bunker will focus on leading Research and Development (R&D) in San Diego, advancing the preclinical pipeline and optimizing the Company’s Integrated Discovery Engine.
Julie Brown is currently Chief Operating and Financial Officer, Burberry Group.
Patients with moderate or elevated risk in the test should immediately consult a cardiologist for further diagnosis and workup
This inspection continues a series of successful inspections by Swissmedic in Vionnaz with the first inspection in 2015 followed by 2016, 2017 and 2020.
Subscribe To Our Newsletter & Stay Updated
